Rivaroxaban

Rivaroxaban is a factor Xa inhibitor used to treat deep vein thrombosis (DVT) and pulmonary embolism (PE). May also be used as thrombosis prophylaxis in specific situations. It is a NOAC (Novel Oral Anticoagulant Agent).

Therapy Area: Cardiovascular
Form: Tablet
Packaging: 1x10 Tablets

COMPOSITION:

Rivaroxaban 10/15/20mg Tablets

MODE OF ACTION:

Rivaroxaban competitively inhibits free and clot bound factor Xa. Factor Xa is needed to activate prothrombin (factor II) to thrombin (factor IIa). Thrombin is a serine protease that is required to activate fibrinogen to fibrin, which is the loose meshwork that completes the clotting process. Since one molecule of factor Xa can generate more than 1000 molecules of thrombin, selective inhibitors of factor Xa are profoundly useful in terminating the amplification of thrombin generation. The action of rivaroxaban is irreversible.

INDICATIONS

  • Deep Vein Thrombosis (DVT)
  • Pulmonary Embolism (PE)

Dosage

As per doctor’s direction

Disclaimer:

This information is for registered medical practitioner only. Anyone other than medical practitioner should consult medical practitioner before using this product.

Enquire About Rixavin

Fill the form below and we will get in touch with you

    This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.